2-11796465-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001349206.2(LPIN1):​c.1886+978C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.102 in 152,076 control chromosomes in the GnomAD database, including 976 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.10 ( 976 hom., cov: 32)

Consequence

LPIN1
NM_001349206.2 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.530

Publications

3 publications found
Variant links:
Genes affected
LPIN1 (HGNC:13345): (lipin 1) This gene encodes a magnesium-ion-dependent phosphatidic acid phosphohydrolase enzyme that catalyzes the penultimate step in triglyceride synthesis including the dephosphorylation of phosphatidic acid to yield diacylglycerol. Expression of this gene is required for adipocyte differentiation and it also functions as a nuclear transcriptional coactivator with some peroxisome proliferator-activated receptors to modulate expression of other genes involved in lipid metabolism. Mutations in this gene are associated with metabolic syndrome, type 2 diabetes, acute recurrent rhabdomyolysis, and autosomal recessive acute recurrent myoglobinuria (ARARM). This gene is also a candidate for several human lipodystrophy syndromes. [provided by RefSeq, Mar 2017]
LPIN1 Gene-Disease associations (from GenCC):
  • myoglobinuria, acute recurrent, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia
  • hereditary recurrent myoglobinuria
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.138 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001349206.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LPIN1
NM_001349206.2
MANE Select
c.1886+978C>G
intron
N/ANP_001336135.1
LPIN1
NM_001261428.3
c.2033+978C>G
intron
N/ANP_001248357.1
LPIN1
NM_001349207.2
c.1976+978C>G
intron
N/ANP_001336136.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LPIN1
ENST00000674199.1
MANE Select
c.1886+978C>G
intron
N/AENSP00000501331.1
LPIN1
ENST00000256720.6
TSL:1
c.1778+978C>G
intron
N/AENSP00000256720.2
LPIN1
ENST00000404113.6
TSL:1
n.1371+978C>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.102
AC:
15513
AN:
151958
Hom.:
977
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0254
Gnomad AMI
AF:
0.0910
Gnomad AMR
AF:
0.106
Gnomad ASJ
AF:
0.130
Gnomad EAS
AF:
0.0874
Gnomad SAS
AF:
0.0813
Gnomad FIN
AF:
0.153
Gnomad MID
AF:
0.165
Gnomad NFE
AF:
0.140
Gnomad OTH
AF:
0.122
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.102
AC:
15506
AN:
152076
Hom.:
976
Cov.:
32
AF XY:
0.101
AC XY:
7489
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.0253
AC:
1049
AN:
41498
American (AMR)
AF:
0.106
AC:
1616
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.130
AC:
450
AN:
3472
East Asian (EAS)
AF:
0.0874
AC:
451
AN:
5158
South Asian (SAS)
AF:
0.0810
AC:
388
AN:
4792
European-Finnish (FIN)
AF:
0.153
AC:
1619
AN:
10568
Middle Eastern (MID)
AF:
0.163
AC:
48
AN:
294
European-Non Finnish (NFE)
AF:
0.140
AC:
9546
AN:
67984
Other (OTH)
AF:
0.121
AC:
256
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
727
1454
2182
2909
3636
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
180
360
540
720
900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0627
Hom.:
84
Bravo
AF:
0.0949
Asia WGS
AF:
0.0740
AC:
256
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
1.1
DANN
Benign
0.58
PhyloP100
-0.53
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11695610; hg19: chr2-11936591; API